# Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

> **NCT02381418** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 120 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza subunit vaccine Influvac

## Key facts

- **NCT ID:** NCT02381418
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381418, "Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02381418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*